rs5068
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006172.4(NPPA):c.*92T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0497 in 1,253,368 control chromosomes in the GnomAD database, including 1,814 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.045 ( 196 hom., cov: 32)
Exomes 𝑓: 0.050 ( 1618 hom. )
Consequence
NPPA
NM_006172.4 3_prime_UTR
NM_006172.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.517
Genes affected
NPPA (HGNC:7939): (natriuretic peptide A) The protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. This gene is located adjacent to another member of the natriuretic family of peptides on chromosome 1. [provided by RefSeq, Oct 2015]
CLCN6 (HGNC:2024): (chloride voltage-gated channel 6) This gene encodes a member of the voltage-dependent chloride channel protein family. Members of this family can function as either chloride channels or antiporters. This protein is primarily localized to late endosomes and functions as a chloride/proton antiporter. Alternate splicing results in both coding and non-coding variants. Additional alternately spliced variants have been described but their full-length structure is unknown. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 1-11845917-A-G is Benign according to our data. Variant chr1-11845917-A-G is described in ClinVar as [Benign]. Clinvar id is 1296345.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0538 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPPA | NM_006172.4 | c.*92T>C | 3_prime_UTR_variant | 3/3 | ENST00000376480.7 | NP_006163.1 | ||
NPPA-AS1 | NR_037806.1 | n.1479+151A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPPA | ENST00000376480.7 | c.*92T>C | 3_prime_UTR_variant | 3/3 | 1 | NM_006172.4 | ENSP00000365663 | P1 | ||
CLCN6 | ENST00000446542.5 | n.781+151A>G | intron_variant, non_coding_transcript_variant | 1 | ||||||
NPPA | ENST00000376476.1 | c.*92T>C | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000365659 | ||||
CLCN6 | ENST00000400892.3 | c.*1961+151A>G | intron_variant, NMD_transcript_variant | 3 | ENSP00000496938 |
Frequencies
GnomAD3 genomes AF: 0.0453 AC: 6892AN: 152162Hom.: 196 Cov.: 32
GnomAD3 genomes
AF:
AC:
6892
AN:
152162
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0503 AC: 55414AN: 1101088Hom.: 1618 Cov.: 15 AF XY: 0.0501 AC XY: 28272AN XY: 564866
GnomAD4 exome
AF:
AC:
55414
AN:
1101088
Hom.:
Cov.:
15
AF XY:
AC XY:
28272
AN XY:
564866
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0453 AC: 6896AN: 152280Hom.: 196 Cov.: 32 AF XY: 0.0470 AC XY: 3498AN XY: 74448
GnomAD4 genome
AF:
AC:
6896
AN:
152280
Hom.:
Cov.:
32
AF XY:
AC XY:
3498
AN XY:
74448
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
56
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at